company background image
A014570 logo

Korean Drug KOSDAQ:A014570 Stock Report

Last Price

₩6.64k

Market Cap

₩72.5b

7D

0.5%

1Y

5.1%

Updated

25 Apr, 2024

Data

Company Financials

Korean Drug Co., Ltd.

KOSDAQ:A014570 Stock Report

Market Cap: ₩72.5b

A014570 Stock Overview

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea.

A014570 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends1/6

Korean Drug Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Korean Drug
Historical stock prices
Current Share Price₩6,640.00
52 Week High₩7,980.00
52 Week Low₩5,870.00
Beta0.20
1 Month Change-5.01%
3 Month Change-3.77%
1 Year Change5.06%
3 Year Change-39.91%
5 Year Change-13.88%
Change since IPO232.00%

Recent News & Updates

Recent updates

Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?

Mar 11
Should You Be Adding Korean Drug (KOSDAQ:014570) To Your Watchlist Today?

Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?

Feb 19
Korean Drug (KOSDAQ:014570) Is Growing Earnings But Are They A Good Guide?

Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 01
Korean Drug Co., Ltd.'s (KOSDAQ:014570) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?

Jan 11
Is Korean Drug Co., Ltd. (KOSDAQ:014570) Popular Amongst Insiders?

Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?

Dec 24
Can You Imagine How Jubilant Korean Drug's (KOSDAQ:014570) Shareholders Feel About Its 111% Share Price Gain?

Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today

Dec 06
Here's Why I Think Korean Drug (KOSDAQ:014570) Might Deserve Your Attention Today

Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 18
Are Korean Drug's (KOSDAQ:014570) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Shareholder Returns

A014570KR PharmaceuticalsKR Market
7D0.5%5.5%3.4%
1Y5.1%8.1%7.1%

Return vs Industry: A014570 underperformed the KR Pharmaceuticals industry which returned 8.1% over the past year.

Return vs Market: A014570 underperformed the KR Market which returned 7.1% over the past year.

Price Volatility

Is A014570's price volatile compared to industry and market?
A014570 volatility
A014570 Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement4.6%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.8%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A014570 has not had significant price volatility in the past 3 months.

Volatility Over Time: A014570's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980n/aHai Parkwww.nicepharma.com

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd.

Korean Drug Co., Ltd. Fundamentals Summary

How do Korean Drug's earnings and revenue compare to its market cap?
A014570 fundamental statistics
Market cap₩72.46b
Earnings (TTM)-₩4.92b
Revenue (TTM)₩81.37b

0.9x

P/S Ratio

-14.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A014570 income statement (TTM)
Revenue₩81.37b
Cost of Revenue₩44.03b
Gross Profit₩37.35b
Other Expenses₩42.27b
Earnings-₩4.92b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-450.58
Gross Margin45.90%
Net Profit Margin-6.04%
Debt/Equity Ratio0%

How did A014570 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.